Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2008-3-4
pubmed:abstractText
Prostate cancer is the third leading cause of cancer death in the United States, following lung and colorectal cancer. We previously identified WDR19 as a prostate-specific, androgen-regulated gene. Here, we evaluate its utility as a prostate cancer tissue marker for diagnosis and prognostic evaluation.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
14
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1397-406
pubmed:meshHeading
pubmed-meshheading:18316561-Adenocarcinoma, pubmed-meshheading:18316561-Animals, pubmed-meshheading:18316561-Antibodies, Monoclonal, pubmed-meshheading:18316561-Blotting, Western, pubmed-meshheading:18316561-Follow-Up Studies, pubmed-meshheading:18316561-Gene Expression Profiling, pubmed-meshheading:18316561-Gene Expression Regulation, Neoplastic, pubmed-meshheading:18316561-Humans, pubmed-meshheading:18316561-Immunoenzyme Techniques, pubmed-meshheading:18316561-Male, pubmed-meshheading:18316561-Mice, pubmed-meshheading:18316561-Neoplasm Recurrence, Local, pubmed-meshheading:18316561-Oligonucleotide Array Sequence Analysis, pubmed-meshheading:18316561-Prognosis, pubmed-meshheading:18316561-Prostate-Specific Antigen, pubmed-meshheading:18316561-Prostatic Hyperplasia, pubmed-meshheading:18316561-Prostatic Neoplasms, pubmed-meshheading:18316561-Proteins, pubmed-meshheading:18316561-RNA, Messenger, pubmed-meshheading:18316561-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:18316561-Sensitivity and Specificity, pubmed-meshheading:18316561-Survival Rate, pubmed-meshheading:18316561-Time Factors, pubmed-meshheading:18316561-Tumor Markers, Biological
pubmed:year
2008
pubmed:articleTitle
WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrence.
pubmed:affiliation
Zhejiang-California International Nanosystems Institute, Hangzhou, China. bylin@u.washington.edu
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural